Revolution Medicines, Inc.

NASDAQ:RVMD

46.18 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q3
Operating Activities:
Net Income -133.233-116.003-161.537-108.434-98.298-68.098-56.507-73.329-61.222-57.647-52.676-52.94-44.299-37.176-34.204-27.221-27.215-19.519-14.596-12.818-10.119-10.131-11.339
Depreciation & Amortization 2.7972.7632.8582.1451.7732.5332.5992.4332.3342.292.0621.7511.8411.6781.71.631.6711.5440.8650.8730.8110.7930.691
Deferred Income Tax 00-0.043-3.86700-0.419-0.2960000000.35900-0.716-4.3730000
Stock Based Compensation 19.77516.20825.42713.66612.989.6998.3168.1388.0986.6446.1975.8275.3133.3872.6322.672.0171.5671.3980.8540.5060.4030.281
Change In Working Capital -4.74-47.21321.199-2.7321.275-2.949-13.60412.182-4.953-7.1144.2457.7772.371-5.6694.252-4.53.449-11.5050.648-2.542-2.671-4.263-1.61
Accounts Receivables 01.254-0.9452.2011.4850.6780.2670.684-0.2410.5461.483-0.8851.037-1.1712.906-1.9681.1190.2870.213-0.064-0.954-0.629-1.395
Change In Inventory 00-10.946-1.64412.59000003.6012.0881.8670.126-1.33900000000
Change In Accounts Payables -4.08-28.9624.3050.588.634-1.05-1.50710.239-0.952-0.4922.5730.1891.608-2.1314.616-3.372.143-3.0844.233-0.4721.3060.1970.092
Other Working Capital -0.66-19.5078.785-3.867-1.434-2.577-12.3641.259-3.76-7.168-3.4126.385-2.141-2.493-1.931-1.131.306-8.421-3.585-2.07-3.977-4.46-1.702
Other Non Cash Items 16.68333.125-8.467-1.277-4.851-3.576-2.173-0.8650.0270.6670.9070.9970.6930.5340.2270.40.0870.6114.406-0.224-0.0290.5930.201
Operating Cash Flow -128.167-160.56-120.563-100.497-67.121-62.391-61.788-51.737-55.716-55.16-39.265-36.588-34.081-37.246-25.034-27.021-19.991-28.018-11.652-13.857-11.502-12.605-11.776
Investing Activities:
Investments In Property Plant And Equipment -2.399-3.167-2.317-2.535-1.119-1.758-2.876-3.525-2.526-1.889-1.183-0.454-1.312-3.579-1.169-0.687-0.474-0.603-0.51-1.107-0.631-0.341-0.216
Acquisitions Net 00884.05-79.88742.425-5.7544.228119.913-64.92700000000000000.16
Purchases Of Investments -374.855-701.681-519.605-170.039-176.175-193.097-160.335-212.964-127.652-111.818-110.814-168.248-278.235-114.038-44.876-194.052-205.167-100.038-28.584-88.276-55.40600
Sales Maturities Of Investments 485.198456.882141.52249.926133.75198.851156.10793.051192.579157.732120.53138.525156.765119.926108.99193.77269.14540.92537.11129.579000
Other Investing Activites 110.343-244.799-884.0579.887-42.4255.754-4.228-119.91364.92745.9149.716-29.723-121.475.88864.115-100.28-136.022-59.1130.0040.0050.0856.1020.16
Investing Cash Flow 107.944-247.966-380.40277.352-43.5443.996-7.104-123.43862.40144.0258.533-30.177-122.7822.30962.946-100.967-136.496-59.7168.021-59.799-55.9525.761-0.056
Financing Activities:
Debt Repayment 00000000000000000000000
Common Stock Issued 7.5040.812.5461.01162.053323.70649.919248.1260.4950.30510.0960.319-0.564281.709-0.034167.801-1.417253.717100.0280000.019
Common Stock Repurchased 003.3170001.8640001.8750000.8320-1.3360-0.045000-0.131
Dividends Paid 00000000000000000000000
Other Financing Activities 7.5040.81833.49102.5770.499-0.420.2090.9340.305-1.2430.3191.4320.5550.6871.0820.0810.027-101.56210.00590.1730.0144.202
Financing Cash Flow 7.5040.81839.3541.01164.63324.20551.363248.3351.4290.30510.7280.3190.868282.2641.485168.883-1.336253.744-1.53410.00590.1730.0144.221
Other Information:
Effect Of Forex Changes On Cash 00-0.6400000000000000000000
Net Change In Cash -12.719-407.716337.749-22.134-46.035265.81-17.52973.168.114-10.83-20.004-66.446-155.995247.32739.39740.895-157.823166.01-5.165-63.65122.719-6.83-7.611
Cash At End Of Period 275.713288.432696.148360.79382.924428.959163.149180.678107.51899.404110.234130.238196.684352.679105.35265.95525.06182.88316.87322.03885.68962.9769.8